<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">SARS-CoV-2 infection can also be ascertained by the detection of antibodies to SARS-CoV-2, which may be helpful in aiding in the diagnosis of post-infectious inflammatory syndromes in children. The first detectable serological marker is total antibodies,
 <xref rid="bib70" ref-type="bibr">
  <sup>70</sup>
 </xref> although IgM and IgG enzyme-linked immunosorbent assay (ELISA) have been documented as positive as early as four days after symptom onset.
 <xref rid="bib63" ref-type="bibr">
  <sup>63</sup>
 </xref> Seroconversion typically occurs in the third to fourth week after illness and ELISA-based IgM and IgG antibody tests have revealed a high specificity for the diagnosis of SARS-CoV-2,
 <xref rid="bib63" ref-type="bibr">
  <sup>63</sup>
 </xref> although false positive results have been described
 <xref rid="bib71" ref-type="bibr">
  <sup>71</sup>
 </xref> and cross-reactivity between other coronaviruses may occur.
 <xref rid="bib72" ref-type="bibr">
  <sup>72</sup>
 </xref> While specific sensitivity quantification is difficult to delineate with regard to serology in children, it is known that paucisymptomatic patients (which describes the vast majority of paediatric cases) may have low antibody concentrations and in these circumstances, false negative results are more likely to occur.
 <xref rid="bib73" ref-type="bibr">
  <sup>73</sup>
 </xref>
</p>
